menu
    • menu

    Company profile for METiS Therapeutics

    NEW Drugs in Dev: 2
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The METiS platform (AiTEM) combines state-of-the-art AI data-driven algorithms, mechanism- driven quantum mechanics and molecular dynamics simulations to calculate Active Pharmaceutical Ingredient (API) properties, elucidate API-target and API-excipient interactions, and predict chemical, physical and pharmacokinetic properties of small molecule and nucleic acid therapeutics in specific microenvironments. This enables efficien...
    The METiS platform (AiTEM) combines state-of-the-art AI data-driven algorithms, mechanism- driven quantum mechanics and molecular dynamics simulations to calculate Active Pharmaceutical Ingredient (API) properties, elucidate API-target and API-excipient interactions, and predict chemical, physical and pharmacokinetic properties of small molecule and nucleic acid therapeutics in specific microenvironments. This enables efficient lead optimization, candidate selection and formulation design. Founded by a team of MIT researchers, serial entrepreneurs and biotech industry veterans.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    METiS TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    245 Main St Cambridge, MA 02142
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://metistx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/metistx/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Metis Techbio Releases Consecutive Research In Nature
    Metis Techbio Releases Consecutive Research In Nature

    16 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/breakthrough-progress-metis-techbio-publishes-consecutive-research-findings-in-nature-communications-and-the-journal-for-immunotherapy-of-cancer-302643333.html

    PR NEWSWIRE
    16 Dec 2025
    Share Share
    Metis Biotech Completes China's First Ai-Enabled Drug Phase III
    Metis Biotech Completes China's First Ai-Enabled Drug Phase III

    23 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/metis-biotech-announces-chinas-first-ai-enabled-formulation-drug-candidate-to-complete-phase-iii-clinical-trial-302592862.html

    PR NEWSWIRE
    23 Oct 2025
    Share Share
    Metis Unveils First AI Nanoforge Delivery Platform
    Metis Unveils First AI Nanoforge Delivery Platform

    29 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/metis-launches-worlds-first-ai-driven-nano-delivery-platform-nanoforge-302569593.html

    PR NEWSWIRE
    29 Sep 2025
    Share Share
    METiS Pharma Appoints Mark Herbert as Chief Business Officer
    METiS Pharma Appoints Mark Herbert as Chief Business Officer

    03 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/metis-pharmaceuticals-appoints-mark-herbert-as-chief-business-officer-302389833.html

    PR NEWSWIRE
    03 Mar 2025
    Share Share
    METIS Phase 3 Trial Met Primary Endpoint, Demonstrating a Significant Extension
    METIS Phase 3 Trial Met Primary Endpoint, Demonstrating a Significant Extension

    27 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240327203177/en

    BUSINESSWIRE
    27 Mar 2024
    Share Share
    METiS Announces License Agreement with Evopoint Biosciences
    METiS Announces License Agreement with Evopoint Biosciences

    06 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230106005012/en

    BUSINESSWIRE
    06 Jan 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search